Glatiramer Acetate ...

Glatiramer Acetate CAS No. 147245-92-9 Peptide
Glatiramer Acetate CAS No. 147245-92-9 Peptide
Glatiramer Acetate CAS No. 147245-92-9 Peptide
Glatiramer Acetate CAS No. 147245-92-9 Peptide
Glatiramer Acetate CAS No. 147245-92-9 Peptide

Glatiramer Acetate CAS No. 147245-92-9 Peptide

Min.Order / FOB Price:Get Latest Price

1 Gram

FOB Price: USD 15.0000

  • Min.Order :1 Gram
  • Purity: 99%
  • Payment Terms : T/T,Other

Keywords

Peptides Pharmaceutical Intermediate Chemical

Quick Details

  • Appearance:White Powder
  • Application:bodybuilding pharmaceutical material, Steroid hormone, Anabolin. As a male hormone and anabolic hormones.
  • PackAge:Packaging can be according to customer
  • ProductionCapacity:10000|Metric Ton|Day
  • Storage:Keep it under seal in cool and dark place
  • Transportation:FEDEX DHL TNT UPS EUB

Superiority:

This is Allen  from Zhengzhou Filter Biotechnology Co.,Ltd.We are the professional supplier of peptide products in China over 10 years. we have Professional Lab to confirm the Quality and Serive for all clients in long-term run cooperation.
Our Company as a Pharmaceutical Raw Material Manufacturer specialize in R&D the New Drugs and Producing the Generic Medicine:

Amino Acids&Vitamins
Pharmaceutical Polypeptide,
Comestic Polypeptide,
Veterinary Peptide and 
Pharmaceutical APIs.
Due to of the high quality and good service, They have been exported more than 30 countries. 
Sincerely hope to have a chance to cooperate with you

Details:

Description
 
latiramer acetate (also known as Copolymer 1, Cop-1, or Copaxone - as marketed by Teva Pharmaceuticals) is animmunomodulator drug currently used to treat multiple sclerosis. It is a random polymer of four amino acids found inmyelin basic protein, namely glutamic acid, lysine, alanine, and tyrosine, and may work as a decoy for the immune system. Glatiramer acetate is approved by the Food and Drug Administration (FDA) for reducing the frequency of relapses, but not for reducing the progression of disability. Observational studies, but not randomized controlled trials, suggest that it may reduce progression of disability.
 
Although the clinical definition of multiple sclerosis requires two or more episodes of symptoms and signs, glatiramer acetate is approved for treatment after single episodes. It is also used to treat relapsing-remitting multiple sclerosis. It is administered by subcutaneous injection.

 

Related Searches

Confirm to collect the product to my collection?

OKCancel

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View